Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 9 open reading frame 50 (C9orf50) encodes a human protein of 431 amino acids (~47.6 kDa) whose function is currently unknown. It contains a DUF4685 domain (domain of unknown function), is highly conserved across mammals, and exists in multiple alternatively spliced forms. The C9orf50 protein localizes mainly to the nucleus but is also found in mitochondria and cytosol. Expression is generally low across most tissues but is relatively higher in testes, brain, and gallbladder. There are no well-established roles in cellular processes, nor any known protein or small molecule ligands or interacting drugs. Recent research has focused on the gene's methylation status as a promising epigenetic biomarker for colorectal cancer, with no direct therapeutic action or targetability demonstrated to date. In summary, C9orf50 is an uncharacterized nuclear protein with no current evidence of being a receptor, enzyme, or other classic druggable target, but it is gaining attention as a cancer biomarker due to its aberrant methylation pattern in colorectal tumors.
None known, as no drugs or inhibitors have been described for C9orf50
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 9 open reading frame 50 (C9orf50).